Table 3 The complications in patients undergoing septoplasty surgery
Postoperative evaluation time | Pregabalin group (%) Number | Gabapentin group (%) Number | Control group (%) Number | P value |
|---|---|---|---|---|
2 h | 0.001 | |||
Yes | (0%)0 | (0%)0 | (0%)0 | |
No | (100%)34 | (100%)34 | (100%)34 | |
Total | (100%)34 | (100%)34 | (100%)34 | |
6 h | 0.025 | |||
Yes | (2.9%)1 | (14.7%)5 | (26.5%)9 | |
No | (97.1%)33 | (85.3%)29 | (73.5%)25 | |
Total | (100%)34 | (100%)34 | (100%)34 | |
16 h | 0.121 | |||
Yes | (2.9%)1 | (0%)0 | (11.8%)4 | |
No | (97.1%)33 | (100%)34 | (88.2%)30 | |
Total | (100%)34 | (100%)34 | (100%)34 |